ZURICH, Sept 24 Novartis on Thursday named Harvard Medical School cancer specialist James Bradner as head of biomedical research with a seat on its executive committee as of March 2016.
Bradner succeeds Mark Fishman, who is retiring after a 13-year stint leading the Swiss company's drug discovery and early clinical development efforts.
01:43 Trump's revised travel ban will target same seven countries: report12
00:07 Uber will release its first diversity report in the next few months15
20:21 Report: Jaguars trade Julius Thomas to Dolphins9
20:21 Dolphins reportedly agree to acquire tight end Julius Thomas from Jaguars7